
### [NCIT:C8973](http://purl.obolibrary.org/obo/NCIT_C8973)
**Label:** Endometrioid Stromal Sarcoma

**Subclasses:** [NCIT:C40223](http://purl.obolibrary.org/obo/NCIT_C40223) (Uterine Corpus Low Grade Endometrial Stromal Sarcoma), [NCIT:C126998](http://purl.obolibrary.org/obo/NCIT_C126998) (Uterine Corpus High Grade Endometrial Stromal Sarcoma), [NCIT:C40222](http://purl.obolibrary.org/obo/NCIT_C40222) (Low Grade Endometrioid Stromal Sarcoma of the Cervix), [NCIT:C40063](http://purl.obolibrary.org/obo/NCIT_C40063) (Ovarian Low Grade Endometrioid Stromal Sarcoma), [NCIT:C4263](http://purl.obolibrary.org/obo/NCIT_C4263) (Low Grade Endometrioid Stromal Sarcoma), [NCIT:C40271](http://purl.obolibrary.org/obo/NCIT_C40271) (Low Grade Endometrioid Stromal Sarcoma of the Vagina), [NCIT:C40219](http://purl.obolibrary.org/obo/NCIT_C40219) (Uterine Corpus Endometrial Stromal Sarcoma), 

**Class expressions from DL-Learner:**

- [NCIT:C53995](http://purl.obolibrary.org/obo/NCIT_C53995) (Endometrioid Stromal Cell) 55.56%
- Thing 53.45%
- [NCIT:C33921](http://purl.obolibrary.org/obo/NCIT_C33921) (Endometrial Stromal Cell) 52.78%
- [NCIT:C53995](http://purl.obolibrary.org/obo/NCIT_C53995) (Endometrioid Stromal Cell) and [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 52.78%
- [CL:0000499](http://purl.obolibrary.org/obo/CL_0000499) (stromal cell) and [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 52.78%
- [CL:0000499](http://purl.obolibrary.org/obo/CL_0000499) (stromal cell) and (not ([CL:0000214](http://purl.obolibrary.org/obo/CL_0000214) (synovial cell))) 40.91%
- [CL:0000499](http://purl.obolibrary.org/obo/CL_0000499) (stromal cell) and (not ([CL:0000138](http://purl.obolibrary.org/obo/CL_0000138) (chondrocyte))) 40.91%
- [CL:0000499](http://purl.obolibrary.org/obo/CL_0000499) (stromal cell) 37.18%
- [CL:0000499](http://purl.obolibrary.org/obo/CL_0000499) (stromal cell) and (not ([NCIT:C39103](http://purl.obolibrary.org/obo/NCIT_C39103) (ERBB2 Signaling Pathway))) 37.18%
- [CL:0000499](http://purl.obolibrary.org/obo/CL_0000499) (stromal cell) and (not ([NCIT:C39102](http://purl.obolibrary.org/obo/NCIT_C39102) (Skeletal Myogenesis Pathway))) 37.18%
- [CL:0000499](http://purl.obolibrary.org/obo/CL_0000499) (stromal cell) and (not ([NCIT:C39101](http://purl.obolibrary.org/obo/NCIT_C39101) (Human Cytomegalovirus Infection Pathway))) 37.18%
- [CL:0000499](http://purl.obolibrary.org/obo/CL_0000499) (stromal cell) and (not ([NCIT:C39094](http://purl.obolibrary.org/obo/NCIT_C39094) (Inhibition of Cellular Proliferation by Gleevec Pathway))) 37.18%
- [CL:0000499](http://purl.obolibrary.org/obo/CL_0000499) (stromal cell) and (not ([NCIT:C39092](http://purl.obolibrary.org/obo/NCIT_C39092) (Growth Hormone Signaling Pathway))) 37.18%
- [CL:0000499](http://purl.obolibrary.org/obo/CL_0000499) (stromal cell) and (not ([NCIT:C39091](http://purl.obolibrary.org/obo/NCIT_C39091) (Corticosteroid Cardioprotection Pathway))) 37.18%
- [CL:0000499](http://purl.obolibrary.org/obo/CL_0000499) (stromal cell) and (not ([NCIT:C39088](http://purl.obolibrary.org/obo/NCIT_C39088) (G2/M Checkpoint Pathway))) 37.18%


